Status:
COMPLETED
Miltefosine for Mucosal Leishmaniasis
Lead Sponsor:
AB Foundation
Conditions:
Leishmaniasis
Eligibility:
All Genders
12+ years
Phase:
PHASE1
PHASE2
Brief Summary
This trial will study miltefosine as a treatment for mucosal leishmaniasis.
Detailed Description
Treat bolivian mucosal leishmaniasis with miltefosine.
Eligibility Criteria
Inclusion
- Mucosal leishmaniasis
Exclusion
- Abnormal liver function tests (LFT)
- Abnormal kidney function test
- Concomitant diseases
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
End Date :
May 1 2006
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT00373776
Start Date
April 1 2004
End Date
May 1 2006
Last Update
September 8 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Palos Blancos, Bolivia